May 2024
1. FREEMAN D
   Developing psychological treatments for psychosis.
   Br J Psychiatry. 2024;224:147-149.
   

   >> Share

   
   
2. FERNANDEZ-EGEA E, Chen S, Sanguesa E, Gasso P, et al
   The role of psychosis and clozapine load in excessive checking in treatment-resistant schizophrenia: longitudinal observational study.
   Br J Psychiatry. 2024;224:164-169.
   

   >> Share

   
   April 2024
3. QI R, Qureshi M, Gire N, Chaudhry IB, et al
   Ethnic density and first episode psychosis in the British Pakistani population: findings from the East Lancashire Early Intervention Service.
   Br J Psychiatry. 2024 Apr 18:1-6. doi: 10.1192/bjp.2024.
   

   >> Share

   
   March 2024
4. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
   Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium - CORRIGENDUM.
   Br J Psychiatry. 2024 Mar 18:1. doi: 10.1192/bjp.2024.
   

   >> Share

   
   February 2024
5. HASSIOTIS A, Noor M, Bebbington P, Ali A, et al
   Borderline intellectual functioning and psychosis: Adult Psychiatric Morbidity Survey evidence - CORRIGENDUM.
   Br J Psychiatry. 2024 Feb 13:1. doi: 10.1192/bjp.2024.
   

   >> Share

   
   January 2024
6. MCCUTCHEON RA, Cannon A, Parmer S, Howes OD, et al
   How to classify antipsychotics: time to ditch dichotomies?
   Br J Psychiatry. 2024;224:20-25.
   

   >> Share

   
   November 2023
7. SAHIN D, Kambeitz-Ilankovic L, Wood S, Dwyer D, et al
   Algorithmic fairness in precision psychiatry: analysis of prediction models in individuals at clinical high risk for psychosis.
   Br J Psychiatry. 2023 Nov 8:1-11. doi: 10.1192/bjp.2023.
   

   >> Share

   
   October 2023
8. LAMBE S, Cooper K, Fazel S, Freeman D, et al
   Psychological framework to understand interpersonal violence by forensic patients with psychosis.
   Br J Psychiatry. 2023 Oct 20:1-8. doi: 10.1192/bjp.2023.
   

   >> Share

   
   
9. KOHLER-FORSBERG O, Ge F, Hauksdottir A, Thordardottir EB, et al
   Adverse childhood experiences and psychological functioning among women with schizophrenia or bipolar disorder: population-based study.
   Br J Psychiatry. 2023 Oct 18:1-7. doi: 10.1192/bjp.2023.
   

   >> Share

   
   
10. BONIVENTO C, Kambeitz-Ilankovic L, Maggioni E, Borgwardt S, et al
    Neurocognitive skills and vulnerability for psychosis in depression and across the psychotic spectrum: findings from the PRONIA Consortium.
    Br J Psychiatry. 2023;223:485-492.
    

    >> Share

    
    August 2023
11. JIN H, Kolawole O, Wang Z
    Cost-effectiveness analysis of physical activity interventions for people with schizophrenia or bipolar disorder: systematic review.
    Br J Psychiatry. 2023;223:362-376.
    

    >> Share

    
    
12. KELLEHER I
    Author's Reply. RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394-395.
    

    >> Share

    
    
13. GRIFFITHS SL, Brown L, Kirkbride JB
    RE: Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023;223:394.
    

    >> Share

    
    July 2023
14. FERNANDEZ-EGEA E, Mucci A, Lee J, Kirkpatrick B, et al
    A new era for the negative symptoms of schizophrenia.
    Br J Psychiatry. 2023;223:269-270.
    

    >> Share

    
    
15. AYMERICH C, Catalan A, Salazar de Pablo G
    RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336.
    

    >> Share

    
    
16. KIRKPATRICK B, Luther L, Strauss GP
    Negative symptoms in the clinic: we treat what we can describe.
    Br J Psychiatry. 2023;223:271-272.
    

    >> Share

    
    
17. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Author's Reply. RE: Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023;223:336-337.
    

    >> Share

    
    
18. CHEN EYH, Wong SMY, Hui CLM, Suen YN, et al
    The emergence of primary negative symptoms: relevance of timing?
    Br J Psychiatry. 2023;223:280-281.
    

    >> Share

    
    June 2023
19. HOWES O, Fusar-Poli P, Osugo M
    Treating negative symptoms of schizophrenia: current approaches and future perspectives.
    Br J Psychiatry. 2023 Jun 5:1-4. doi: 10.1192/bjp.2023.
    

    >> Share

    
    
20. BYNG R, Creanor S, Jones B, Hosking J, et al
    The effectiveness of a primary care-based collaborative care model to improve quality of life in people with severe mental illness: PARTNERS2 cluster randomised controlled trial.
    Br J Psychiatry. 2023;222:246-256.
    

    >> Share

    
    
21. NORTHWOOD K, Pearson E, Arnautovska U, Kisely S, et al
    Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis.
    Br J Psychiatry. 2023;222:241-245.
    

    >> Share

    
    May 2023
22. GALDERISI S, Kaiser S
    The pathophysiology of negative symptoms of schizophrenia: main hypotheses and open challenges.
    Br J Psychiatry. 2023 May 26:1-3. doi: 10.1192/bjp.2023.
    

    >> Share

    
    
23. PENADES R, Wykes T
    Use of cognitive remediation to treat negative symptoms in schizophrenia: is it time yet?
    Br J Psychiatry. 2023 May 17:1-2. doi: 10.1192/bjp.2023.
    

    >> Share

    
    
24. SALAZAR DE PABLO G, Catalan A, Vaquerizo Serrano J, Pedruzo B, et al
    Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis.
    Br J Psychiatry. 2023 May 17:1-13. doi: 10.1192/bjp.2022.
    

    >> Share

    
    March 2023
25. CELLA M, Roberts S, Pillny M, Riehle M, et al
    Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses.
    Br J Psychiatry. 2023 Mar 15:1-11. doi: 10.1192/bjp.2023.
    

    >> Share

    
    January 2023
26. KELLEHER I
    Psychosis prediction 2.0: why child and adolescent mental health services should be a key focus for schizophrenia and bipolar disorder prevention research.
    Br J Psychiatry. 2023 Jan 12:1-3. doi: 10.1192/bjp.2022.
    

    >> Share

    
    
27. WOLPE N, Chen S, Kirkpatrick B, Jones PB, et al
    Longitudinal effect of clozapine-associated sedation on motivation in schizophrenia: naturalistic longitudinal study.
    Br J Psychiatry. 2023 Jan 10:1-3. doi: 10.1192/bjp.2022.
    

    >> Share

    
    
28. O'BRIEN KJ, Ered A, Korenic SA, Olino TM, et al
    Childhood trauma, perceived stress and anhedonia in individuals at clinical high risk for psychosis: multigroup mediation analysis.
    Br J Psychiatry. 2023 Jan 5:1-7. doi: 10.1192/bjp.2022.
    

    >> Share

    
    December 2022
29. AHANGARI M, Bustamante D, Kirkpatrick R, Nguyen TH, et al
    Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia.
    Br J Psychiatry. 2022 Dec 12:1-8. doi: 10.1192/bjp.2022.
    

    >> Share

    
    
30. IKKOS G, Stanghellini G
    Sensibility and schizophrenia: Wilhelm Waiblinger on Friedrich Holderlin's life, poetry and madness - psychiatry in literature.
    Br J Psychiatry. 2022;221:739.
    

    >> Share

    
    
31. BUTLER E, Pillinger T, Brown K, Borgan F, et al
    Real-world clinical and cost-effectiveness of community clozapine initiation: mirror cohort study.
    Br J Psychiatry. 2022;221:740-747.
    

    >> Share

    
    November 2022
32. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis - CORRIGENDUM.
    Br J Psychiatry. 2022 Nov 14:1. doi: 10.1192/bjp.2022.
    

    >> Share

    
    September 2022
33. WATSON AJ, Harrison L, Preti A, Wykes T, et al
    Cognitive trajectories following onset of psychosis: a meta-analysis.
    Br J Psychiatry. 2022 Sep 23:1-8. doi: 10.1192/bjp.2022.
    

    >> Share

    
    August 2022
34. LAHTEENVUO M, Luykx JJ, Taipale H, Mittendorfer-Rutz E, et al
    Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts.
    Br J Psychiatry. 2022 Aug 25:1-8. doi: 10.1192/bjp.2022.
    

    >> Share

    
    July 2022
35. FLEETWOOD K, Wild SH, Smith DJ, Mercer SW, et al
    Association of severe mental illness with stroke outcomes and process-of-care quality indicators: nationwide cohort study.
    Br J Psychiatry. 2022;221:394-401.
    

    >> Share

    
    May 2022
36. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make? - CORRIGENDUM.
    Br J Psychiatry. 2022 May 23:1. doi: 10.1192/bjp.2022.
    

    >> Share

    
    April 2022
37. CURTIS D
    Identification of specific genes involved in schizophrenia aetiology - what difference does it make?
    Br J Psychiatry. 2022 Apr 6:1-3. doi: 10.1192/bjp.2021.
    

    >> Share

    
    February 2022
38. ANTONUCCI LA, Penzel N, Sanfelici R, Pigoni A, et al
    Using combined environmental-clinical classification models to predict role functioning outcome in clinical high-risk states for psychosis and recent-onset depression.
    Br J Psychiatry. 2022 Feb 14:1-17. doi: 10.1192/bjp.2022.
    

    >> Share

    
    
39. CUI Y, Li C, Liu B, Sui J, et al
    Consistent brain structural abnormalities and multisite individualised classification of schizophrenia using deep neural networks.
    Br J Psychiatry. 2022 Feb 11:1-8. doi: 10.1192/bjp.2022.
    

    >> Share

    
    January 2022
40. LEE R, Leighton SP, Thomas L, Gkoutos GV, et al
    Prediction models in first-episode psychosis: systematic review and critical appraisal.
    Br J Psychiatry. 2022 Jan 24:1-13. doi: 10.1192/bjp.2021.
    

    >> Share

    
    December 2021
41. XI YB, Wu XS, Cui LB, Bai LJ, et al
    Neuroimaging-based brain-age prediction of first-episode schizophrenia and the alteration of brain age after early medication.
    Br J Psychiatry. 2021 Dec 2:1-8. doi: 10.1192/bjp.2021.
    

    >> Share

    
    
42. BAKER SJ, Jackson M, Jongsma H, Saville CWN, et al
    The ethnic density effect in psychosis: a systematic review and multilevel meta-analysis.
    Br J Psychiatry. 2021;219:632-643.
    

    >> Share

    
    
43. BHUI K, Halvorsrud K, Mooney R, Hosang GM, et al
    Is psychosis a syndemic manifestation of historical and contemporary adversity? Findings from UK Biobank.
    Br J Psychiatry. 2021;219:686-694.
    

    >> Share

    
    
44. ELLETT L, Chadwick P
    Recommendations for monitoring and reporting harm in mindfulness for psychosis research.
    Br J Psychiatry. 2021;219:629-631.
    

    >> Share

    
    July 2021
45. MCDONALD K, Ding T, Ker H, Dliwayo TR, et al
    Using epidemiological evidence to forecast population need for early treatment programmes in mental health: a generalisable Bayesian prediction methodology applied to and validated for first-episode psychosis in England.
    Br J Psychiatry. 2021;219:383-391.
    

    >> Share

    
    
46. VAN DER MEER L, Kaiser S, Castelein S
    Negative symptoms in schizophrenia: reconsidering evidence and focus in clinical trials.
    Br J Psychiatry. 2021;219:359-360.
    

    >> Share

    
    
47. CASTELEIN S, Timmerman ME, van der Gaag M, Visser E, et al
    Clinical, societal and personal recovery in schizophrenia spectrum disorders across time: states and annual transitions.
    Br J Psychiatry. 2021;219:401-408.
    

    >> Share

    
    
48. ZHU Y, Wang S, Gong X, Edmiston EK, et al
    Associations between hemispheric asymmetry and schizophrenia-related risk genes in people with schizophrenia and people at a genetic high risk of schizophrenia.
    Br J Psychiatry. 2021;219:392-400.
    

    >> Share

    
    
49. BHATTACHERJEE S, Young A, Ahuja N, Allen S, et al
    Should intramuscular clozapine be adopted into mainstream clinical practice?
    Br J Psychiatry. 2021;219:357-358.
    

    >> Share

    
    May 2021
50. SISKIND D, Orr S, Sinha S, Yu O, et al
    Rates of treatment-resistant schizophrenia from first-episode cohorts: systematic review and meta-analysis.
    Br J Psychiatry. 2021 May 11:1-6. doi: 10.1192/bjp.2021.
    

    >> Share

    
    October 2020
51. FOND G, Pauly V, Bege T, Orleans V, et al
    Trauma-related mortality of patients with severe psychiatric disorders: population-based study from the French national hospital database.
    Br J Psychiatry. 2020;217:568-574.
    

    >> Share

    
    May 2020
52. OHI K, Shimada T, Kataoka Y, Yasuyama T, et al
    Genetic correlations between subcortical brain volumes and psychiatric disorders.
    Br J Psychiatry. 2020;216:280-283.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share